P8Z Stock Analysis: Bumitama Agri | SG
Farm Products | SG, Singapore | Market Cap: 3.087m SGD | 12M Return: 29.4% | SG2E67980267 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.77M
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bumitama Agri Ltd. is an Indonesia-based investment holding company engaged in the production and trading of crude palm oil (CPO) and palm kernel (PK). The company operates an integrated value chain spanning oil palm plantations, palm oil mills, and a fertilizer blending plant. It cultivates, harvests, and processes fruit from oil palm trees to produce and sell CPO and PK, while also providing business, management, and consultancy services, and trading in edible oils and related products. Founded in 1996, Bumitama is headquartered in Jakarta Selatan, Indonesia.
Indonesia is the worlds largest producer of crude palm oil, and the industry is a major contributor to the countrys export economy. Vertically integrated producers like Bumitama control the supply chain from plantation cultivation through milling and downstream trading, which is a common business model aimed at capturing margin across multiple stages and managing input costs such as fertilizer internally.
- CPO prices rise on tight global edible oil supply
- Indonesia biodiesel mandate expansion lifts domestic demand
- EU deforestation rules pressure export volumes and pricing
| Net Income: 2803b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 4.94 > 1.0 |
| NWC/Revenue: 16.60% < 20% (prev 24.14%; Δ -7.53% < -1%) |
| CFO/TA 0.20 > 3% & CFO 4672b > Net Income 2803b |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.73b) vs 12m ago 0.0% < -2% |
| Gross Margin: 27.96% > 18% (prev 26.04%; Δ 1.92% > 0.5%) |
| Asset Turnover: 88.32% > 50% (prev 77.68%; Δ 10.63% > 0%) |
| Interest Coverage Ratio: 18.50 > 6 (EBIT TTM 3093b / Interest Expense TTM 167b) |
| A: 0.14 (Total Current Assets 7008b - Total Current Liabilities 3695b) / Total Assets 23643b |
| B: 0.60 (Retained Earnings 14150b / Total Assets 23643b) |
| C: 0.14 (EBIT TTM 3093b / Avg Total Assets 22591b) |
| D: 2.75 (Book Value of Equity 15540b / Total Liabilities 5657b) |
| Altman-Z'' = 6.67 = AAA |
| DSRI: 0.21 (Receivables 191b/776b, Revenue 19951b/16732b) |
| GMI: 0.93 (GM 26.04% / 27.96%) |
| AQI: 0.93 (AQ_t 0.10 / AQ_t-1 0.10) |
| SGI: 1.19 (Revenue 19951b / 16732b) |
| TATA: -0.08 (NI 2803b - CFO 4672b) / TA 23643b) |
| Beneish M = -3.65 (Cap -4..+1) = AAA |
As of October 23, 2026, the stock is trading at SGD 1.68 with a total of 2,140,800 shares traded. Over the past week, the price has changed by -10.16%, over one month by -27.27%, over three months by -6.91% and over the past year by +29.39%.
Current recommended Stop Loss: 1.50 (which is 10.7% or 1.6 ATR below the current price).
Bumitama Agri has no consensus analysts rating.
Market Cap IDR = 43389b (3.09b SGD * 14056.453125 SGD.IDR)
P/E Trailing = 11.8667
P/E Forward = 12.87
P/S = 2.2873
P/B = 3.2823
P/EG = 0.825
Revenue TTM = 19951b IDR
EBIT TTM = 3093b IDR
EBITDA TTM = 4083b IDR
Long Term Debt = 1586b IDR (from longTermDebt, last quarter)
Short Term Debt = 1757b IDR (from shortLongTermDebt, last quarter)
Debt = unknown
Net Debt = unknown
Enterprise Value = 40093b IDR (43389b + (null Debt) - CCE 3296b)
Interest Coverage Ratio = 18.50 (Ebit TTM 3093b / Interest Expense TTM 167b)
EV/FCF = 12.83x (Enterprise Value 40093b / FCF TTM 3126b)
FCF Yield = 7.80% (FCF TTM 3126b / Enterprise Value 40093b)
FCF Margin = 15.67% (FCF TTM 3126b / Revenue TTM 19951b)
Net Margin = 14.05% (Net Income TTM 2803b / Revenue TTM 19951b)
Gross Margin = 27.96% ((Revenue TTM 19951b - Cost of Revenue TTM 14373b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.70 (Enterprise Value 40093b / Total Assets 23643b)
Interest Expense / Debt = unknown (Interest Expense 167b / Debt none)
Taxrate = 27.79% (1295b / 4660b)
NOPAT = 2233b (EBIT 3093b * (1 - 27.79%))
Current Ratio = 1.90 (Total Current Assets 7008b / Total Current Liabilities 3695b)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 4083b)
Debt / FCF = unknown (Net Debt none / FCF TTM 3126b)
Total Stockholder Equity = 14771b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.41% (Net Income 2803b / Total Assets 23643b)
RoE = 18.97% (Net Income TTM 2803b / Total Stockholder Equity 14771b)
RoCE = 18.91% (EBIT 3093b / Capital Employed (Equity 14771b + L.T.Debt 1586b))
RoIC = 11.78% (NOPAT 2233b / Invested Capital 18951b)
WACC = 5.82% (E(43389b)/V(43389b) * Re(5.82%) + (debt-free company))
Discount Rate = 5.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -52.22 | Cagr: -0.09%
[DCF] Terminal Value 77.97% ; FCFF base≈2589b ; Y1≈2968b ; Y5≈4368b
[DCF] Fair Price = 37.9k (EV 65725b - Net Debt 0.0 = Equity 65725b / Shares 1.73b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: 97.75 | Revenue CAGR: 13.66% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2154.99 | Chg30d=-2.24% | Revisions=+17% | GrowthEPS=+33.4% | GrowthRev=+17.1%
EPS next Year (2027-12-31): EPS=2203.58 | Chg30d=-1.77% | Revisions=+29% | GrowthEPS=+2.2% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: +30% (up=5, down=2)